baber/WOPTO huggingface dataset:
Patent DE-69606383-T2 (DE)
Inventor: TOMAT FERRUCCIO
IPC: B21B1/18
Filed: 1996-12-06
Granted: 2000-06-21
Abstract: Compact rolling block comprising at least one rolling mill stand having a horizontal axis and at least one rolling mill stand having a vertical axis, two end rolling mill stands having the same axis and being separated by a central rolling mill stand having an axis substantially at 90 DEG  to the axes of the other two end rolling mill stands, the end rolling mill stands (11, 13) cooperating by means of extensions (18a, 18c) with a first gear casing (16) forming a support for a second gear casing (25) associated by means of extensions (18b) with the central rolling mill stand (12), a motor (17b) of the central rolling mill stand (12) being upheld by the first gear casing (16), the extensions (18a, 18c, 18c) associated with the respective rolling mill stands (11, 12, 13) including respective connecting bushes (28a, 28b, 28c) associated with support means (27, 127) which can be positioned by means of actuation units (26, 126) so as to connect/release the relative connecting bushes (28a, 28b, 28c) to/from respective ring-bearing shafts (14). <IMAGE>
Patent DE-69606601-T2 (DE)
Inventor: MAURO MARINA
IPC: C07C231/18
Filed: 1996-05-17
Granted: 2000-07-06
Abstract: The present invention refers to a Process for the preparation of S-(-)-5-[[2-(acetyloxy)-1-oxopropyl]amino]-2,4,6-triiodo-1,3-benzenedicarboxylic acid dichloride of formula (I) comprising the reaction between S-(-)-[2-(acetyloxy)]propionic acid chloride and 5-amino-2,4,6-triiodo-, 1,3-benzenedicarboxylic acid dichloride, in an aprotic dipolar solvent and in presence of a halogenhydric acid.
Patent DE-69613385-T2 (DE)
Inventor: KAWABATA KOHJI
IPC: A61P31/04
Filed: 1996-09-27
Granted: 2001-10-18
Abstract: PCT No. PCT/JP96/02797 Sec. 371 Date Mar. 26, 1998 Sec. 102(e) Date Mar. 26, 1998 PCT Filed Sep. 27, 1996 PCT Pub. No. WO97/12890 PCT Pub. Date Apr. 10, 1997A compound of the formula: wherein R1 is amino, R2 is hydrogen, R3 is carboxy, R4 is heterocyclic(lower)alkylthio wherein said heterocyclic group is pyrazolyl and said lower alkyl group is methyl, and R5 is halogen; and pharmaceutically acceptable salts thereof.
Patent DE-69622432-T2 (DE)
Inventor: BARLOW JOHN
IPC: A61L9/12
Filed: 1996-12-05
Granted: 2003-04-03
Abstract: A device for the controlled release of vapour and a method of dispensing a volatile medium into the air. The device includes a carrier impregnated with a volatile medium and a wrapper of flexible material surrounding said carrier for retaining the volatile medium on the carrier. Said wrapper has at least two contiguous tear strips disposed over the carrier that may be successively removed to expose a portion of the carrier of increasing size without any need to provide for relative movement of the wrapper and carrier. The method of dispensing a volatile medium into the air includes providing such a device, removing a first tear strip to expose a portion of the carrier, and subsequently removing an additional tear strip to expose a fresh area of carrier to maintain the concentration of volatile medium at desired level.
Patent DE-69628987-T2 (DE)
Inventor: KUPIECKI DAVID
IPC: A61M25/00
Filed: 1996-10-07
Granted: 2004-05-27
Abstract: This is a medical catheter made up of a body having on its distal end portion an expandable balloon and, proximal of the balloon, a delivery lumen ending in a port through which therapeutic or diagnostic agents may be delivered. In one variation, a single inflation/wire lumen extends from the catheter proximal end to the catheter distal end, through which the balloon is inflated with pressurized fluid and through which a guide wire extends. The guide wire may have a valve plug for selectively seating against a valve seat of the catheter distal end to seal the inflation/wire lumen for balloon inflations. In another variation, a vaso-occlusive agent is disposable within a delivery lumen in a catheter coupled with a steerable guidewire. The delivery lumen ends in a delivery port near to and proximal of an expandable balloon located at the catheter's end. A single inflation/wire lumen may also be provided for facilitating both balloon inflation and guide wire tracking. <IMAGE>   <IMAGE>
Patent DE-69703303-T2 (DE)
Inventor: GARCIA J
IPC: H05K13/04
Filed: 1997-08-15
Granted: 2001-02-15
Abstract: An electronic component preprocessing assembly comprises a press pin plate having a surface from which at least one press pin depends, a load plate having at least one loading aperture spatially aligned with and sized to receive the press pin, a pin holder plate having a surface from which at least one orienting pin depends, and a carrier plate having at least one component passageway spatially aligned with and sized to receive the orienting pin. The load plate and the carrier plate are spatially aligned so that an electronic component initially placed in the loading aperture can travel to the component passageway while captured within a predetermined distance between the press pin and the orienting pin. The predetermined distance is preferably sufficient to prevent unnecessary pressure on the component captured therein while orienting the component in a preferred orientation during transfer.
Patent DE-69703777-T2 (DE)
Inventor: FAYMONVILLE YVES
IPC: B62D53/06
Filed: 1997-09-30
Granted: 2001-06-21
Abstract: The trailer can be hitched to any towing vehicle, particularly by drawbar, or a swan-neck, to form a semi-trailer. It has one or more axles (5), each in two halves (7). These have a hydraulic or air-suspension system, and are combined with steering gear for the wheels (29). The halves can have stub-axles, and they can each have a bearing fixed to the chassis and extended by a suspension arm supporting the axle body. A lifting ram operated independently can be provided for each half. Steering can be by rods with two joints and driven by a ram-operated steering rod, together with a steering lever on the wheel.
Patent DE-69704424-T2 (DE)
Inventor: DURAND GERARD
IPC: C08J9/02
Filed: 1997-06-04
Granted: 2001-11-08
Abstract: The invention relates to the field of polymer chemistry. It features a method for obtaining polyols consisting in a first step in reacting glycols, i.e. plurialcohols with a functionality at least equal to two (MEG,DEG,DPG, . . . ) on polyethyleneterephthalate (PET) in the presence of a transesterefication catalyst (CAT) (MEG,DEG,DPG; . . . ), on polyethyleneterephthalate (PET) in the presence of a glycolysis catalyst (CAT), then in a last step, comprises, in distilling the free glycols. The method is characterized in that a step subsequent to the first and prior to, or simultaneous with, the last step, comprises the glycolysis catalyst deactivation by a deactivating agent (DES). As an example, the glycolysis reaction catalyst (CAT) is one of the agents of the group comprising zinc acetate and manganese acetate, amines such as triethylamine and tributylamine, and the selected deactivating agent is phosphoric acid at 85%.
Patent DE-69717436-T2 (DE)
Inventor: DAO-CONG DONG
IPC: A01N25/34
Filed: 1997-04-09
Granted: 2003-07-17
Abstract: Water-dispersible powder formulations used in connection with seed treatment and foliar treatment of plants provide excellent dust and rub-off control. The powder formulations comprise an active ingredient, a wetting agent, a dispersant, an anticaking agent, and an adhesion ingredient selected from the group consisting of a sodium salt of a polyacrylic acid, a sodium salt of maleic acid/acrylic acid copolymer, polyvinyl pyrrolidone, an alkylated polyvinyl pyrrolidone, and mixtures thereof. The wetting agent is present in an amount that is effective for enabling the powder formulation to be wettable by cold water. The dispersant is present in an amount that is effective for enabling the powder formulation to be dispersible in cold water. The anticaking agent is present in an amount that is effective for enabling the powder formulation to be re-suspendable in water. The adhesion ingredient is present in an amount that is effective for enabling the powder formulation to adhere to a plant leaf or seed. The powder formulations are especially suitable for containment in water soluble and/or water-dispersible bags or pouches, such use tending to render the active ingredient safer to handle and therefore better for consumers and the environment.
Patent DE-69726586-T2 (DE)
IPC: B65D51/28
Filed: 1997-06-24
Granted: 2004-11-04
Abstract: A closure cap having therein a blister pack in which an additive, which may be a tablet, is retained to be released into the liquid contents of an associated bottle simultaneously upon opening of the closure cap and the rupturing of said blister pack by part of a closure member and forming part of the closure cap, whereafter the contents of the container may be dispensed either through the closure cap or after removal of the closure cap.
Patent DE-69732912-T2 (DE)
Inventor: COOK E
IPC: A23K1/16
Filed: 1997-01-21
Granted: 2006-03-30
Abstract: A method of improving the efficiency of an animal to convert feed into desirable body tissue involves feeding the animal feed particles having an inner core of nutrients and an outer layer of fat containing antibodies which can passively immunise the animal against antibodies than can adversely affect the animal's ability to grow or efficiently convert its feed into body tissue.
Patent DE-69735656-T2 (DE)
Inventor: GALE ROBERT M
IPC: A61K31/70
Filed: 1997-07-15
Granted: 2006-08-24
Abstract: Composition of matter for application to a body surface or membrane to administer fluoxetine by permeation through the body surface or membrane, the composition comprising fluoxetine to be administered, at a therapeutically effective rate, alone or in combination with a permeation enhancer or mixture. A preferred embodiment is directed to the transdermal administration of fluoxetine at reduced skin irritation levels wherein fluoxetine, preferably provided as fluoxetine acetate, is coadministered with a corticosteroid such as hydrocortisone. Also disclosed are drug delivery devices containing the fluoxetine or fluoxetine and enhancer composition and methods for the transdermal administration of the fluoxetine and fluoxetine/enhancer composition.                                             00000
Patent DE-69810634-T2 (DE)
Inventor: GREENLEES ERROL JAMES STEWART
IPC: G09F11/00
Filed: 1998-03-18
Granted: 2003-10-16
Abstract: A poster display system for displaying a plurality of different images which includes an image grid with interlaced strips from the various images, masking grid adjacent the image grid having spaced apart masking strips alternating with spaced apart window strips, a mounting system for mounting the image grid and the masking grid for movement relative to one another, a drive mechanism for producing relative movement between the image grid and the masking grip between successive display positions in which the window strips of the masking grid are aligned with image strips of a particular image, the image strips of the other images being obscured by the masking strips, and compression means for urging opposite edge portions of the image grid and of the masking grip towards each other whereby the image grid and the masking grid become curved and the image grid and the masking grid are brought into intimate contact with one another under pressure.
Patent DE-69811882-T2 (DE)
Inventor: BOUGAMONT JEAN-LOUIS
IPC: B65D47/34
Filed: 1998-05-28
Granted: 2004-03-18
Abstract: The invention concerns a pump comprising a substantially cylindrical body (1) defining internally a metering chamber (11) whereof the lower end (1a) is provided with an intake orifice (10) equipped with a valve (12) and the upper end is provided with an outlet (20a) and closed by a piston (2) capable of moving in said chamber (11) by cooperating with elastic return means (4) outside the chamber (11), between a support up stop and a limit down stop. Said piston (2) comprises a central core (21) integral with the bottom end (23a) of a hollow axial rod (23) whereof the top end (23b) projects outside the metering chamber (11) and a coaxial sleeve (22), connected to said rod (23) by an elastic articulation (24) ensuring a sealed contact with the chamber (11) internal wall and defining with said core (21) a ring-shaped evacuating conduit (20) capable of being opened by displacement of said sleeve (22) with respect to the core (21), and the pump body (1) upper part being closed by a flange (3) whereof the internal surface forms the piston (2) up stop and the external surface serves as bottom support for the elastic return means (4). Said flange (3) is provided with an axial bore (30) wherein moves the hollow rod (23) integral with the piston. The invention is characterized in that said sleeve comprises a top ring (22b) designed to be urged into sealed engagement in a peripheral groove (31) arranged in said flange (3) internal surface.
Patent DE-69813435-T2 (DE)
Inventor: LECRIVAIN ALAIN
IPC: B21B13/02
Filed: 1998-10-09
Granted: 2003-10-16
Abstract: Rolls in a rolling mill cage are changed using a guidance chassis and a device with a hook to pick up the intermediate rolls or the work rolls alone or the whole assembly by their ends. A device for changing rolls in a rolling mill cage comprises a guidance chassis (29) with an extraction device (28) to slide parallel to the axes of the rolls. A device (35) for picking up each of the work rolls (4) by its end and a moveable hook (37) for each of the two intermediate rolls (3), for the demounting and remounting either the two work rolls (4) alone or the assembly of work rolls (4). This also applies to the intermediate rolls (3) of which the dressings (6) roll on rails (8, 9) and are arranged respectively on the cage (1) on the guidance chassis. An Independent claim is also included for the method for changing rolls using this device.
Patent DE-69828220-T2 (DE)
Inventor: BECKER GARY J
IPC: A61F2/91
Filed: 1998-05-06
Granted: 2006-06-08
Abstract: An expandable intraluminal endoprosthesis comprising a tubular member (1) a first diameter which permits intraluminal delivery of the member into a lumen of a body passageway, particularly a blood vessel. The tubular member (1) is capable of acquiring a second, expanded and deformed diameter upon the application from the interior of the tubular member of a radially outwardly extending force, which second diameter is variable and dependent on the amount of said force applied to the tubular member. Such a tubular member may be expanded and deformed to expand the lumen of the body passageway. According to the invention the wall of said tubular member is formed by a continuous filament (2) which is separated from a tube wall. Said filament (2) comprises a number of adjacent undulations which are staggered in a substantially helical configuration advancing around a longitudinal axis of the tubular body. A first helical turn (A-H) of said filament around said longitudinal axis of said tubular member is connected to an adjacent second such turn (A-H) of said filament by means of at least one connection element (31,32) which is an integral extension of said filament. <IMAGE>
Patent DE-69835536-T2 (DE)
Inventor: BALABAN NAOMI
IPC: A61P31/00
Filed: 1998-12-18
Granted: 2007-08-09
Abstract: The invention features methods and compositions for treatment or prevention of infection by, or disease caused by infection with, Staphylococcus spp., particularly S. aureus.
Patent DE-69904718-T2 (DE)
Inventor: GAULIER JEAN-PAUL
IPC: A23C19/06
Filed: 1999-05-10
Granted: 2003-10-02
Abstract: The invention concerns a method for making a cheese product by processing an initial material consisting of a cheese, comprising the following steps: a) thermal and mechanical treatment such as kneading the initial cheese, after fractionating into strands at a temperature T1 of not more than 65  DEG C, to break down in limited manner the initial cheese protein structure; b) cooling the mixture resulting from step a) to a temperature ranging between T1-8  DEG C and T1-20  DEG C, advantageously between T1-10  DEG C and T1-15  DEG C inclusively; c) if necessary, mechanically treating the paste resulting from step b) in an endless screw apparatus to complete the reconstruct of the protein structure and stabilise the emulsion; and, wherein steps a) and b) are carried out by adding to the initial raw material an amount of water of not less than 7 wt.% and not more than 20 wt.% with respect to the initial material weight.
Patent DE-69908643-T2 (DE)
Inventor: SIKORSKI A
IPC: A61K31/44
Filed: 1999-12-17
Granted: 2004-05-13
Abstract: The present invention provides combinations of cardiovascular therapeutic compounds for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia, atherosclerosis, or hyperlipidemia. Combinations disclosed include a nicotinic acid derivative combined with a cholesteryl ester transfer protein (CETP) inhibitor.
Patent DE-69923156-T2 (DE)
Inventor: LIPIAN JOHN-HENRY
IPC: C08F4/80
Filed: 1999-10-05
Granted: 2005-12-29
Abstract: Methods for the addition polymerization of cycloolefins using a cationic Group 10 metal complex and a weakly coordinating anion of the formula:wherein [(R')zM(L')x(L'')y] is a cation complex where M represents a Group 10 transition metal; R' represents an anionic hydrocarbyl containing ligand; L' represents a Group 15 neutral electron donor ligand; L'' represents a labile neutral electron donor ligand; x is 1 or 2; and y is 0, 1, 2, or 3; and z is 0 or 1, wherein the sum of x, y, and z is 4; and [WCA] represents a weakly coordinating counteranion complex; and b and d are numbers representing the number of times the cation complex and weakly coordinating counteranion complex are taken to balance the electronic charge on the overall catalyst complex.
Patent DE-69929092-T2 (DE)
Inventor: DAMGAARD LARS RIIS
IPC: A61B5/0275
Filed: 1999-10-04
Granted: 2006-07-06
Abstract: The invention relates to a method and a sensor for measurement of tissue perfusion. The sensor is provided with a reservoir ( 4 ) for a fluid or gaseous tracer and a tracer-permeable barrier ( 3 ), a sub-surface of which is in contact with the surrounding tissue and another sub-surface of which is in contact with a detection cavity ( 5 ) which is connected to a suitable apparatus for the measurement of tracer concentration in the detection cavity. The concentration of the tracer in the detection cavity is a measure of perfusion in the surrounding tissue. According to another embodiment of the invention it is also possible to carry out measurements of perfusion in the surface layers of the skin or of an organ.
Patent DE-69933485-T2 (DE)
Inventor: BABA TOSHIYUKI
IPC: C12N9/96
Filed: 1999-04-23
Granted: 2007-01-11
Abstract: A method for stabilizing an alanine aminotransferase in at least one medium selected from the group consisting of serum and buffer, the method comprising adding a valine to said medium, and the corresponding compositions.
Patent DE-69933486-T2 (DE)
Inventor: DENYER JONATHAN STANLEY HAROLD
IPC: A61M11/00
Filed: 1999-10-26
Granted: 2007-07-12
Abstract: A nebuliser comprises means for determining the duration of a pulse of atomisation during inspiration, the determination means including means for measuring the tidal volume of a patient, timing means for measuring the duration of inspiration, means for storing estimates of the volume of a patient's upper airway, and means for calculating the duration of the pulse. The duration of the pulse is calculated on the basis of the tidal volume measured by the tidal volume measuring means, the duration of inspiration measured by the timing means, and the stored estimated volume of patient's upper airway from the storage means.
Patent DE-69934631-T2 (DE)
Inventor: QUATE CALVIN F
IPC: G03F7/20
Filed: 1999-05-28
Granted: 2007-10-04
Abstract: An improved optical photolithography system and method provides predetermined light patterns generated by a direct write system without the use of photomasks. The Direct Write System provides predetermined light patterns projected on a surface of a substrate (e.g., a wafer) by using a computer controlled spatial light modulator. Image patterns are stored in a computer and through electronic control of pixels in the spatial light modulator, directly illuminates the wafer to define a portion of the polymer array, rather than being defined by a pattern on a photomask. For example, in the Direct Write System using a micro-mirror array as the spatial light modulator, the angle of each pixel of micro-mirror array is computer controlled to reflect or not reflect an optical beam of suitable intensity to thereby image (printing) individual features on the substrate at each photolithographic step without using a photomask. The Direct Write System including a spatial light modulator is particularly useful for deprotecting features for polymer array synthesis (e.g. synthesis of DNA arrays). <IMAGE>
Patent DE-69938175-T2 (DE)
Inventor: KIRIHARA CHIKAO
IPC: A61L2/04
Filed: 1999-06-03
Granted: 2009-02-26
Abstract: Connecting to the sterilization chamber an antiseptic gas counteracting and deodorizing device which including a main pipeline having an inlet for antiseptic gas at one end thereof and an outlet for processed gas at the other; a fan connected to said inlet side midway in said main pipeline; a preheater; a decomposition by oxidization means; a cooling means all ranging in this order from said fan to said outlet to connect to each other; and a branch pipe provided between the decomposition by oxidization means of said main pipeline and the cooling means ;      performing sterilization by the use of said sterilizer for a predetermined period of time, circulating the gas for idling between said main pipeline, and said bypass pipe line for a predetermined period of time by said antiseptic gas counteracting and deodorizing device a little before the end of said sterilization process,    then circulating the gas between the sterilization chamber and the main pipeline for counteraction purpose,    introducing a counteractive into the sterilization chamber,    and administering the same treatment as done in said antiseptic.    <IMAGE>
Patent HU-E025821-T2 (HU)
Title: Pharmaceutical combination
Inventor: STEFANIC MARTIN FRIEDRICH
IPC: A61P3/10
Filed: 2009-06-04
Abstract: The present invention relates to a pharmaceutical combination which may be useful for the treatment of diseases which involve cell proliferation, which involve migration or apoptosis of myeloma cells, which involve angiogenesis or which involve fibrosis. The invention also relates to a method for the treatment of said diseases, comprising simultaneous, separate or sequential administration of effective amounts of specific active compounds and/or co-treatment with radiation therapy, in a ratio which provides an additive and synergistic effect, and to the combined use of these specific compounds and/or radiotherapy for the manufacture of corresponding pharmaceutical combination preparations.
Patent HU-E034374-T2 (HU)
Title: Genetically modified mice expressing chimeric major histocompatibility complex (mhc) ii molecules
Inventor: MACDONALD LYNN
Filed: 2012-10-26
Abstract: The invention provides genetically modified non-human animals that express a humanized MHC II protein (humanized MHC II α and β polypeptides), as well as embryos, cells, and tissues comprising the same. Also provided are constructs for making said genetically modified animals and methods of making the same. Methods of using the genetically modified animals to study various aspects of human immune system are provided.